INTRODUCTIONPharmaceutical Industry in the UKThe pharmaceutical industry in the UK directly employs around 72,000 people and in 2010 contributed £8.4 billion to the UK's GDP and invested a total of £3.9 billion in research and development. In 2007, pharmaceutical exports from the UK amounted to £14.6 billion, creating a pharmaceuticals trade surplus of £4.3 billion. The UK is home to GlaxoSmithKline and AstraZeneca, respectively the fifth and sixth largest global pharmaceutical companies as measured by the 2010 market. share. Foreign companies with a major presence in the UK pharmaceutical industry include Pfizer, Novartis, Hoffmann–La Roche and Eisai. One in five of the world's best-selling prescription drugs was developed in the UK. Research and development In 2012 the UK had the third highest share of global spending on pharmaceutical research and development of any nation, at 9% of total, behind the United States (49%) and Japan (15%). The UK has the highest spend on pharmaceutical research and development of any European nation, accounting for 23% of the total; followed by France (20%), Germany (19%) and Switzerland (11%). Pharmaceutical Industry in India The pharmaceutical industry in India is the third largest in the world in terms of volume. According to the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, the total turnover of the Indian pharmaceutical industry between 2008 and September 2009 was $21.04 billion. While the domestic market was worth 12.26 billion dollars. The industry has a market share of $14 billion in the United States. According to the Brand India Equity Foundation, the Indian pharmaceutical market is likely to grow at a compound annual growth rate (CAGR) of 14-17%.... .. center of paper ......steroids, chelators iron, musculoskeletal, neuropsychiatric, nutritional and ophthalmic products, oncology, respiratory, urology and women's health products in various dosage forms. It also provides veterinary products for various animals, including companion animals, equines, general care, livestock and poultry. Additionally, the company offers inhalation medications and devices, such as dry powder inhalers, single-dose capsules and multi-dose dry powder inhalers, breath-activated metered-dose inhalers, non-static spacers, infant and toddler masks, and nasal sprays. It also provides consultancy, commissioning, plant engineering, transfer and technical know-how support services. Cipla has over 2000 products in 65 therapeutic categories available in over 40 dosage forms. Its key products include the following drugs: Escitalopram (antidepressant), Lamivudine, Fluticasone propionate.